» Articles » PMID: 34711211

Associations of Plasma 8-iso-prostaglandin Flevels with Fasting Blood Glucose (FBG) and Intra-abdominal Fat (IAF) Area in Various Glycometabolism Populations

Overview
Publisher Biomed Central
Specialty Endocrinology
Date 2021 Oct 29
PMID 34711211
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study aimed to investigate the differences in oxidative stress (OS) levels represented by 8-iso-prostaglandin F (8-iso-PGF) and analyze its correlation with the intra-abdominal fat (IAF) area and the glycolipid index.

Methods: We recruited a total of 160 eligible subjects. According to the blood glucose levels and the T2DM duration, subjects were divided into three groups: Type 2 Diabetes (T2DM) group, Prediabetic group, and Normal glucose-tolerance (NC) group, containing 66, 41, 53 patients, respectively. T2DM groups were additionally divided into a new-onset T2DM group including 29 patients and a non-new-onset T2DM group including 37 patients. General clinical data and biochemical indicators were collected. Intra-abdominal fat (IAF) was measured by MRI. 8-iso-PGF was measured by ELISA.

Results: Compared with the NC group, levels of systolic blood pressure (SBP), waist-to-hip ratio (WHR), FBG, 2 h postprandial glycemia(2hPG), 2 h insulin (2 h INS), IAF area, HOMA-IR, and 8-iso-PGF increased, and high-density lipoprotein cholesterol (HDL-C) decreased in T2DM groups and Prediabetic group (P < 0.05). The 2 h INS level was the highest in the Prediabetic group; 2hPG, and IAF area were the highest in the new-onset T2DM group; WHR, FBG, HOMA-IR and 8-iso-PGF were the highest in the non-new-onset T2DM group. Multiple stepwise regression analysis identified IAF area and FBG as the strongest and independent determinant of 8-iso-PGF (P < 0.01).

Conclusions: In various glycometabolism populations, 8-iso-PGF2α is significantly correlated with FBG and IAF, this suggests that high blood glucose and abdominal obesity can increase the damage related to the OS in vivo.

References
1.
Tangvarasittichai S . Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes. 2015; 6(3):456-80. PMC: 4398902. DOI: 10.4239/wjd.v6.i3.456. View

2.
Jia X, Wang S, Ma N, Li X, Guo L, Liu X . Comparative analysis of vaspin in pregnant women with and without gestational diabetes mellitus and healthy non-pregnant women. Endocrine. 2014; 48(2):533-40. DOI: 10.1007/s12020-014-0318-7. View

3.
Costacou T, Zgibor J, Evans R, Tyurina Y, Kagan V, Orchard T . Antioxidants and coronary artery disease among individuals with type 1 diabetes: Findings from the Pittsburgh Epidemiology of Diabetes Complications Study. J Diabetes Complications. 2006; 20(6):387-94. DOI: 10.1016/j.jdiacomp.2005.10.007. View

4.
Sampson M, Elwell-Sutton T, Bachmann M, Clark A, Dhatariya K, Ferns C . Discordance in glycemic categories and regression to normality at baseline in 10,000 people in a Type 2 diabetes prevention trial. Sci Rep. 2018; 8(1):6240. PMC: 5908912. DOI: 10.1038/s41598-018-24662-y. View

5.
Angelova P, Abramov A . Role of mitochondrial ROS in the brain: from physiology to neurodegeneration. FEBS Lett. 2018; 592(5):692-702. DOI: 10.1002/1873-3468.12964. View